Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Dec 13, 2019NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an...
- Nov 21, 2019Conference call to be held on November 21, 2019 at 4:30 p.m. Eastern time
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
- Nov 14, 2019Secures exclusive worldwide license for Nondispersive Infrared (NDIR) laser technology
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the...
- Nov 7, 2019Unprecedented six-month maintenance-free implant duration achieved
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Nov 6, 2019
NEW YORK, Nov. 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Nov 5, 2019PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to CommercializationExtends cash runway to support multiple milestones including commercialization of two lead products
NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it...
- Sep 5, 2019Conference call to be held on September 5, 2019 at 4:30 p.m. Eastern time
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
- Aug 21, 2019
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Aug 15, 2019All 20 patients underwent successful CarpX procedures while passing primary effectiveness endpoint, with all follow-up patients to date passing primary safety endpoint
NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Aug 7, 2019
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Jun 26, 2019
NEW YORK, June 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the...
- Jun 24, 2019
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced...
- May 21, 2019Conference call to be held on May 21, 2019 at 4:30 p.m. Eastern time
NEW YORK, May 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
May 20, 2019First nine patients undergo successful CarpX procedures as part of FIH clinical safety studyNEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...
- May 6, 2019
NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that...
Apr 24, 2019Resorbable pediatric ear tube expected to benefit up to one million U.S. children per yearNEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Apr 12, 2019
NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it...
- Apr 4, 2019Conference call to be held on April 4, 2019 at 4:30 p.m. Eastern time
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
- Mar 21, 2019
NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
Mar 20, 2019Groundbreaking disposable gravity-driven intravenous (IV) infusion set achieves flow accuracy comparable to expensive electronic infusion pumps, independent of IV bag height.NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
Mar 13, 2019Groundbreaking implantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in pre-clinical testingNEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Feb 28, 2019
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced...
-
Feb 26, 2019
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an...
- Jan 10, 2019
NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an...
Nov 29, 2018NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Nov 15, 2018Conference call to be held on November 15, 2018 at 4:30 p.m. Eastern time
NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
- Nov 1, 2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Oct 23, 2018
NEW YORK, Oct, Oct. 23, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today...
- Oct 17, 2018
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an...
Aug 14, 2018Conference call to be held August 22, 2018 at 4:30 p.m. Eastern timeNEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reported...
- Aug 9, 2018
NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced...
- Jul 25, 2018FDA confirms receipt of CarpX 510(k) resubmission for review
NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided its...
-
Jul 11, 2018Medical device veteran joins as company approaches important regulatory and commercial milestones
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has named...
-
Jul 9, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that The Nasdaq...
-
Jun 27, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided a business update...
-
Jun 12, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced the closing of its...
-
Jun 8, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced its previously...
-
Jun 1, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that its board of directors has...
-
May 23, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, previously announced on May 8, 2018 that the...
-
May 22, 2018Conference call to be held May 30, 2018 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today reports financial results for...
-
May 18, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company will host a...
-
May 15, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW)) (“PAVmed”), a highly differentiated, multiproduct medical device company, announced today that its board of directors approved a...
-
May 14, 2018PAVmed subsidiary Lucid Diagnostics Inc. secures exclusive worldwide license for EsoCheck
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMZ), a highly differentiated, multi-product medical device company, today announced it has finalized a definitive licensing agreement with...
-
Apr 24, 2018PAVmed subsidiary to receive exclusive worldwide license to commercialize EsoCheck
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a highly differentiated, multi-product medical device company, today announced that it has signed a letter of intent with Case...
-
Apr 11, 2018Conference call begins at 4:30 p.m. Eastern time today
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, today reports financial results for the three and 12...
-
Apr 5, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the final results of its previously...
-
Apr 4, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company will host a...
-
Apr 4, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the preliminary results of its...
-
Mar 16, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that its previously disclosed offer...
-
Mar 14, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that Lishan Aklog, M.D., PAVmed’s...
-
Feb 21, 2018Warrant Exchange Offer to Extend Until March 19, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the filing of a warrant exchange...
-
Feb 12, 2018New Warrants to be Identical to Those Issuable in Recently Announced Rights Offering
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced it intends to file exchange offer...
-
Feb 9, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the completion of its previously...
-
Jan 25, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it has completed the sale of...
-
Jan 23, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the closing of its previously announced...
-
Jan 19, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced the pricing of its previously announced...
-
Jan 18, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW)) (“PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it intends to offer shares of...
-
Jan 17, 2018Each Right Will Entitle Holder to Purchase One New Unit
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that the Company has set the terms...
-
Jan 11, 2018Tender Offer to Extend Until February 8, 2018
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced the filing of a Tender Offer and...
-
Dec 28, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) (the “Company”), a highly differentiated, multiproduct medical device company, today announced that it intends to temporarily...
Dec 18, 2017Device designed to replace invasive carpal tunnel surgery, addressing an estimated $1 billion market opportunityNEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that CarpX™, its minimally invasive device designed...
-
Nov 28, 2017Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that it has filed a 510(k) premarket notification...
-
Nov 15, 2017Conference call to be held November 16, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and nine months ended...
-
Nov 9, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
-
Oct 10, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial...
-
Sep 18, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Aug 14, 2017Conference call to be held August 17, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended...
-
Aug 9, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on...
-
Jul 5, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $5 million financing provided by...
-
Jun 23, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that on June 23, 2017, the Securities and Exchange...
-
Jun 22, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced that the Company will join the Russell Microcap® Index...
-
May 22, 2017Conference call to be held May 31, 2017 at 4:30 p.m. Eastern time
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31,...
-
May 16, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update...
-
May 10, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17,...
-
Apr 10, 2017Exchange Structured to Reward Current Security Holders and Incentivize Long-term Ownership by Both Existing and New Investors
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4...
-
Mar 31, 2017Company Presentation Set for April 4th at 12:50 p.m. ET
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM)(Nasdaq:PAVMW), a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation...
-
Mar 28, 2017No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on...
-
Mar 28, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Mar 21, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new...
-
Mar 9, 2017Aggregate Private Placement Proceeds Exceed $2.5 Million
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional...
-
Feb 23, 2017Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common...
-
Feb 17, 2017Fourth Quarter 2016 Financial Results Announced
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the fourth quarter and year ended...
-
Feb 3, 2017
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, announced that at 4:00 pm today the Securities and Exchange Commission...
-
Feb 2, 2017Company Considering Exchange Offers to Enhance Value of Outstanding Securities
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of a $1.5 million financing. The private...
Dec 19, 2016First product regulatory submission marks major corporate milestoneNEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced that it has filed a 510(k) premarket notification...
-
Dec 2, 2016- Third Quarter 2016 Financial Results Announced -
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM,PAVMW), a highly differentiated, multi-product medical device company, today announced financial results for the third quarter ended September...
-
Nov 10, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Nov 4, 2016Agreement provides PAVmed with license to develop and commercialize antibiotic-eluting resorbable ear tube devices expected to benefit up to one million children per year
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has signed a definitive licensing agreement...
-
Oct 28, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the company has filed a registration statement on...
-
Sep 20, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Sep 7, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...
-
Aug 16, 2016- Conference Call to be Held August 17th-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM) (“PAVmed” or the “Company”), a highly-differentiated multi-product medical device company, today announced financial results for the...
-
Aug 12, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on August 17,...
-
Jul 26, 2016-Common Stock (Nasdaq:PAVM) and Warrants (Nasdaq:PAVMW) will trade separately-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that the common stock and warrants underlying the units sold...
-
Jul 26, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that Jan David Wald, Ph.D., Senior Research Analyst at The...
-
Jul 14, 2016-Commercialization of PortIO™ implantable vascular access device anticipated in 2017-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that it has set a Q4 2016 timeline for FDA 510(k) submission...
Jun 22, 2016- Device designed to revolutionize treatment of Carpal Tunnel Syndrome -NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion of a pre-clinical human cadaver study,...
-
May 26, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a...
-
May 13, 2016
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company organized to conceive, develop and commercialize a diversified pipeline of innovative products, today...
-
Apr 28, 2016- Units to Begin Trading Today on Nasdaq Under the Ticker Symbol “PAVMU”-
NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. announced today that it has completed its initial public offering of 1,060,000 units. Each unit consists of one share of common stock and one warrant. The...